Insufficient anticoagulation with dabigatran in a patient with short bowel syndrome

Thromb Haemost. 2014 Aug;112(2):419-20. doi: 10.1160/TH14-02-0104. Epub 2014 Apr 3.

Authors

A Douros¹, L Schlemm, J Bolbrinker, M Ebinger, R Kreutz

Affiliation

¹ Antonios Douros, MD, Department of Clinical Pharmacology and Toxicology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany, Tel.: +49 30 450 525 225, Fax: +49 40 450 7 525 112, E-mail: [email protected].

PMID: 24695752
DOI: 10.1160/TH14-02-0104

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Administration, Oral
Aged, 80 and over
Anticoagulants / administration & dosage*
Anticoagulants / blood
Anticoagulants / pharmacokinetics
Atrial Fibrillation / complications
Atrial Fibrillation / diagnosis
Atrial Fibrillation / drug therapy*
Benzimidazoles / administration & dosage*
Benzimidazoles / blood
Benzimidazoles / pharmacokinetics
Biological Availability
Blood Coagulation / drug effects*
Dabigatran
Drug Monitoring
Drug Substitution
Factor Xa Inhibitors / administration & dosage
Female
Humans
Infarction, Middle Cerebral Artery / diagnosis
Infarction, Middle Cerebral Artery / etiology*
Infarction, Middle Cerebral Artery / prevention & control
Intestinal Absorption
Morpholines / administration & dosage
Predictive Value of Tests
Pyridines / administration & dosage*
Pyridines / blood
Pyridines / pharmacokinetics
Risk Factors
Rivaroxaban
Short Bowel Syndrome / complications*
Short Bowel Syndrome / metabolism
Thiophenes / administration & dosage
Treatment Outcome

Substances

Anticoagulants
Benzimidazoles
Factor Xa Inhibitors
Morpholines
Pyridines
Thiophenes
Rivaroxaban
Dabigatran